(Q34625661)

3 August 2017

1 reference

title

The epidemiology of urinary tract infection (English)

1 reference

3 August 2017

1 reference

1

Betsy Foxman

1 reference

PubMed ID

21139641

3 August 2017

language of work or name

English

0 references

publication date

1 December 2010

1 reference

3 August 2017

Nature Reviews Urology

1 reference

3 August 2017

7

1 reference

3 August 2017

12

1 reference

3 August 2017

653-660

1 reference

https://scigraph.springernature.com/pub.10.1038/nrurol.2010.190

3 August 2017

0 references

cites work

Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.190

Food reservoir for Escherichia coli causing urinary tract infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.190

Epidemics of nosocomial urinary tract infection caused by multiply resistant gram-negative bacilli: epidemiology and control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.190

The impact of prulifloxacin on vaginal lactobacillus microflora: an in vivo study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.190

Antimicrobial resistance of Escherichia coli strains causing community-acquired urinary tract infections among insured and uninsured populations in a large urban center

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.190

Persistent extended-spectrum beta-lactamase urinary tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.190

Community-acquired extended-spectrum beta-lactamase producers, United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.190

Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Infectious Diseases Society of America and the Food and Drug Administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.190

Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.190

Clinical and bacteriological outcome of different doses and duration of pivmecillinam compared with placebo therapy of uncomplicated lower urinary tract infection in women: the LUTIW project.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.190

Asymptomatic bacteriuria--important or not?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.190

Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.190

The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.190

The natural history of lower urinary tract symptoms in females: analysis of a health screening project

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.190

Asymptomatic microscopic or dipstick haematuria in adults: which investigations for which patients? A review of the evidence.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.190

Long-term outcome of patients with a negative work-up for asymptomatic microhematuria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.190

Engineering out the risk for infection with urinary catheters

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.190

Scientific and clinical challenges in the management of urinary tract infections

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.190

Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.190

Community-onset urinary tract infections: a population-based assessment.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.190

Hidden pathogens uncovered: metagenomic analysis of urinary tract infections.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.190

Sexual acquisition of urinary tract infection in a man

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.190

Risk factors for second urinary tract infection among college women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.190

Uropathogenic Escherichia coli Are More Likely than Commensal E. coli to Be Shared between Heterosexual Sex Partners

31 March 2020

2 references

https://api.crossref.org/works/10.1038%2FNRUROL.2010.190

31 March 2020

12 December 2020

The rise and fall of Escherichia coli O 15 in a London Teaching Hospital

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.190

High prevalence of ST131 isolates producing CTX-M-15 and CTX-M-14 among extended-spectrum-beta-lactamase-producing Escherichia coli isolates from Canada

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.190

Community-onset genitourinary tract infection due to CTX-M-15-Producing Escherichia coli among travelers to the Indian subcontinent in New Zealand

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.190

Infections with extended-spectrum beta-lactamase-producing enterobacteriaceae: changing epidemiology and drug treatment choices

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.190

Catheter-associated urinary tract infections in intensive care units can be reduced by prompting physicians to remove unnecessary catheters.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.190

Epidemiology of urinary tract infections: transmission and risk factors, incidence, and costs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.190

Prevalence of nosocomial infections in The Netherlands, 2007-2008: results of the first four national studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.190

Is it necessary to catheterise the bladder routinely before gynaecological laparoscopic surgery?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.190

Presentation, pattern, and natural course of severe symptoms, and role of antibiotics and antibiotic resistance among patients presenting with suspected uncomplicated urinary tract infection in primary care: observational study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.190

Three-day vs longer duration of antibiotic treatment for cystitis in women: systematic review and meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.190

Urinary tract infection: self-reported incidence and associated costs.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.190

Clinical and economic consequences of nosocomial catheter-related bacteriuria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.190

A prospective study of risk factors for symptomatic urinary tract infection in young women.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.190

The epidemiology of acute pyelonephritis in South Korea, 1997-1999.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.190

Detection of intracellular bacterial communities in human urinary tract infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.190

Current concepts of molecular defence mechanisms operative during urinary tract infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.190

Innate and adaptive immune responses in the urinary tract

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.190

Natural history of recurrent urinary tract infections in women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.190

Genetic variation of the human urinary tract innate immune response and asymptomatic bacteriuria in women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.190

Inherited Susceptibility to Acute Pyelonephritis: A Family Study of Urinary Tract Infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.190

Toll-like receptor polymorphisms and susceptibility to urinary tract infections in adult women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.190

Association of the Lewis blood-group phenotype with recurrent urinary tract infections in women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.190

Risk factors for community-acquired urinary tract infection due to quinolone-resistant E. coli.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.190

Little evidence for reversibility of trimethoprim resistance after a drastic reduction in trimethoprim use.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.190

The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.190

Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United States

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.190

Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.190

Antibiotic resistance of Escherichia coli from community-acquired urinary tract infections in relation to demographic and clinical data

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.190

Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.190

Symptomatic treatment (ibuprofen) or antibiotics (ciprofloxacin) for uncomplicated urinary tract infection?--results of a randomized controlled pilot trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2010.190

Condom use and first-time urinary tract infection.

31 March 2020

1 reference

12 December 2020

Canadian guidelines for the management of asymptomatic microscopic hematuria in adults

1 reference

12 December 2020

The diagnosis of urinary tract infection: a systematic review

1 reference

12 December 2020

Randomised controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women

1 reference

12 December 2020

A case of recurrently sexually transmitted urinary tract infection

1 reference

12 December 2020

The relationship between pyuria and infection in patients with indwelling urinary catheters: a prospective study of 761 patients

1 reference

12 December 2020

Definitions, classification, and clinical presentation of urinary tract infections

1 reference

12 December 2020

Antibiotic resistance in community-acquired urinary tract infections: prevalence and risk factors.

1 reference

12 December 2020

Catheter-associated urinary tract infection is rarely symptomatic: a prospective study of 1,497 catheterized patients

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRUROL.2010.190

1 reference

PubMed ID

21139641

Dimensions Publication ID

3 August 2017

0 references

1 reference

PubMed ID

21139641